A general look at our identified factors suggests two separate categories of predictive factors, i.e., the intensity of infection (as indicated by WBC and CRP levels) and the type/resistance of the bacteria, thus accentuating a strong advantage for SSI treatment by early SSI detection and specifically targeted anti-microbial agents. This evidence concerns the gene CRP and infection.